scholarly article | Q13442814 |
P356 | DOI | 10.1080/01635580903191486 |
P8608 | Fatcat ID | release_7bteyctltfenraw6imrfdx5g2a |
P698 | PubMed publication ID | 20043265 |
P50 | author | John C. Mathers | Q43191125 |
P2093 | author name string | Shridhar S Dronamraju | |
Seamus B Kelly | |||
Jonathan M Coxhead | |||
P2860 | cites work | Butyrate- but not TGFbeta1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase. | Q40319429 |
Microarray analysis of butyrate regulated genes in colonic epithelial cells | Q40331870 | ||
GADD45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets | Q40372738 | ||
Activation of CMV promoter-controlled glycosyltransferase and beta -galactosidase glycogenes by butyrate, tricostatin A, and 5-aza-2'-deoxycytidine | Q40428477 | ||
Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. | Q40524225 | ||
Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells | Q40693659 | ||
Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate. | Q40789496 | ||
Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression | Q40893919 | ||
Regulation of human colonic cell line proliferation and phenotype by sodium butyrate | Q41162511 | ||
Selective hypermethylation of transcribed nucleosomal DNA by sodium butyrate. | Q53473170 | ||
Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines. | Q53592250 | ||
Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon | Q57552167 | ||
Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding | Q24299183 | ||
Effects of short chain fatty acids on gut morphology and function | Q24540325 | ||
Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). | Q24548152 | ||
Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells | Q24563114 | ||
DNA mismatch repair status may influence anti-neoplastic effects of butyrate | Q28185190 | ||
Does butyrate protect from colorectal cancer? | Q28295747 | ||
Cyclin-dependent kinase pathways as targets for cancer treatment | Q28306405 | ||
Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats | Q28345117 | ||
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer | Q29615066 | ||
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. | Q34318634 | ||
Short chain fatty acids in human large intestine, portal, hepatic and venous blood | Q34529426 | ||
Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms | Q35124775 | ||
Small-molecule cyclin-dependent kinase modulators | Q35551149 | ||
Nutrition and cancer prevention: diet-gene interactions | Q35614698 | ||
Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers | Q35810106 | ||
Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. | Q36213486 | ||
Structure and function of the components of the human DNA mismatch repair system | Q36521428 | ||
Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats. | Q36959016 | ||
Genes modulated by histone acetylation as new effectors of butyrate activity | Q38299556 | ||
Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. | Q38318863 | ||
Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state | Q40296469 | ||
Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. | Q40309778 | ||
P433 | issue | 1 | |
P921 | main subject | DNA mismatch repair | Q2984243 |
P304 | page(s) | 105-115 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Nutrition and Cancer | Q7070508 |
P1476 | title | Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair | |
P478 | volume | 62 |
Q36367647 | A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers |
Q35380738 | Anticarcinogenic properties of medium chain fatty acids on human colorectal, skin and breast cancer cells in vitro |
Q88170682 | Butyrate Inhibits Indices of Colorectal Carcinogenesis via Enhancing α-Ketoglutarate-Dependent DNA Demethylation of Mismatch Repair Genes |
Q56435752 | Chemoprevention in Lynch syndrome |
Q37723755 | Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation. |
Q36782161 | Development of a bread delivery vehicle for dietary prebiotics to enhance food functionality targeted at those with metabolic syndrome |
Q37798946 | Induction of Epigenetic Alterations by Dietary and Other Environmental Factors |
Q38361952 | Is resistant starch protective against colorectal cancer via modulation of the WNT signalling pathway? |
Q56435837 | Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial |
Q37174716 | The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? |
Search more.